138163-07-2

Basic information

• Product Name: 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
• Synonyms: 1-(N-CBZ-PIPERIDIN-4-YLOXY)ACETIC ACID;4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER;RARECHEM AL BF 0487;N-CBZ-4-PIPERIDINECARBOXYLIC ACID METHYL ESTER;N-CBZ-4-CARBOXYMETHOXY-PIPERIDINE;METHYL 1-CBZ-ISONIPECOTATE;N-Cbz-isonipecotic acid methyl ester;1-CBZ-4-piperidinecarboxylicacimethylester
• CAS NO: 138163-07-2
• Molecular Formula: C₁₅H₁₉NO₄
• Molecular Weight: 293.32
• Product Categories: pharmacetical
• Mol File: 138163-07-2.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 493.8 °C at 760 mmHg
• Flash Point: 252.4 °C
• Appearance: /
• Density: 1.27 g/cm³
• Vapor Pressure: 2.65E-06mmHg at 25°C
• Refractive Index: 1.537
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -2.34±0.40(Predicted)
• CAS DataBase Reference: 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(138163-07-2)
• EPA Substance Registry System: 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER(138163-07-2)

Safety Data

• Hazardous Substances Data: 138163-07-2(Hazardous Substances Data)

Usage

General Description

4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is a chemical compound with a molecular structure containing a piperidine ring and a carboxylic acid group. It is commonly used in the synthesis of pharmaceutical compounds and as a building block in organic chemistry reactions. 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER has potential applications in the development of new drugs and bioactive molecules due to its structural properties and reactivity. Additionally, it may exhibit biological activity and could be used in medicinal chemistry research for the design and discovery of new therapeutic agents. Overall, 4-CARBOXYMETHOXY-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is a versatile chemical with various potential uses in the field of chemistry and pharmaceutical science.

InChI:InChI=1/C15H19NO4/c1-19-14(17)13-7-9-16(10-8-13)15(18)20-11-12-5-3-2-4-6-12/h2-6,13H,7-11H2,1H3

Upstream product

• 2971-79-1 isonipecotic acid methyl ester 
• 501-53-1 benzyl chloroformate 
• 498-94-2 isonipecotic acid 
• 7462-86-4 methyl piperidine-4-carboxylate hydrochloride 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 
• 67-56-1 methanol 
• 286961-24-8 benzyl 1,2,3,6-tetrahydro-4-(trifluoromethylsulphonyloxy)-pyridine-1-carboxylate 
• 10314-98-4 1-benzyloxycarbonylpiperidine-4-carboxylic acid 
• 186581-53-3 diazomethane 

Downstream Products

• 10314-98-4 1-benzyloxycarbonylpiperidine-4-carboxylic acid 
• 161609-80-9 benzyl 4-(hydrazinylcarbonyl)piperidine-1-carboxylate 
• 1061683-37-1 benzyl 4-(2-methoxypropan-2-yl)piperidine-1-carboxylate 
• 160809-39-2 1-(benzyloxycarbonyl)-4-(1-hydroxy-1-methylethyl)piperidine 
• 10314-99-5 benzyl 4-(chlorocarbonyl)piperidine-1-carboxylate 
• 1155860-37-9 C₃₂H₃₄Cl₄N₄O₆S₂ 
• 593261-71-3 C₂₀H₂₂Cl₂N₂O₃S 
• 1155860-74-4 C₂₅H₂₅Cl₂N₂OP 
• 1155860-72-2 C₃₄H₃₄Cl₄N₄O₄ 
• 1155860-70-0 C₂₂H₂₃Cl₂N₃O₇ 
• 1155860-68-6 C₃₃H₃₄Cl₄N₄O₅S 
• 1155860-65-3 C₂₃H₂₆Cl₂N₂O₂ 
• 791012-39-0 N-[(2,4-dichlorophenyl)methyl]-4-piperidinecarboxamide 

Relevant articles and documents

DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER

Present invention relates to novel heterocyclic compounds as indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) modulators. Compounds of the present invention inhibit tryptophan degradation by modulating IDO and/or TDO. Formula (I) The invention further relates to the process of their preparation, pharmaceutical composition and their use in modulating the activity of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3- dioxygenase (TDO). The compounds of the invention can be used alone or in combination for the treatment of conditions that benefits from the inhibition of tryptophan degradation.

POTENT NON-UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of s

Substituted Pyrimidine and Triazine Compounds

Substituted pyrimidine and triazine compounds corresponding to formula I wherein R1, R2, R3, R4a, R4b, R5a, R5b, R7, R8, R9a, R9b, R10, R11, A, a, b, s, t, V, W1, W2 and W3 have defined meanings, pharmaceutical compositions comprising such compounds, a process for preparing such compounds, and the use of such compounds and compositions to treat or inhibit pain and/or other disorders or disease states.